|
ABCC1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.50510764646606E-14 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.441302715539E-11 |
| Normal-vs-Stage2 |
1.40960000005741E-07 |
| Normal-vs-Stage3 |
2.10809147915825E-12 |
| Normal-vs-Stage4 |
1.62736490949555E-12 |
| Stage1-vs-Stage2 |
8.694600E-01 |
| Stage1-vs-Stage3 |
3.696300E-02 |
| Stage1-vs-Stage4 |
1.200470E-03 |
| Stage2-vs-Stage3 |
1.989370E-01 |
| Stage2-vs-Stage4 |
2.986000E-02 |
| Stage3-vs-Stage4 |
3.606400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.19633208789583E-13 |
| Normal-vs-AfricanAmerican |
9.337400E-03 |
| Normal-vs-Asian |
3.0595999955807E-08 |
| Caucasian-vs-AfricanAmerican |
4.124400E-01 |
| Caucasian-vs-Asian |
7.140400E-01 |
| AfricanAmerican-vs-Asian |
3.846400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.41360298203608E-11 |
| Normal-vs-Female |
6.06181771445335E-14 |
| Male-vs-Female |
5.829000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.5211000015114E-08 |
| Normal-vs-Age(41-60Yrs) |
9.88098491916389E-15 |
| Normal-vs-Age(61-80Yrs) |
1.64190883111814E-12 |
| Normal-vs-Age(81-100Yrs) |
2.390100E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.842400E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.075200E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.480800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.811200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.598000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.643000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.833200E-04 |
| Classical-VS-Follicular |
8.958800E-01 |
| Classical-VS-Other |
8.787400E-01 |
| Classical-VS-Normal |
9.51061451814894E-12 |
| Tall-VS-Follicular |
3.798800E-03 |
| Tall-VS-Other |
8.137800E-02 |
| Tall-VS-Normal |
1.79656289844843E-12 |
| Follicular-VS-Other |
9.213600E-01 |
| Follicular-VS-Normal |
1.84089999910597E-08 |
| Other-VS-Normal |
6.184200E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.24007528876791E-13 |
| Normal-vs-N1 |
2.76667577736589E-12 |
| N0-vs-N1 |
6.684300E-02 |
|
|
